alpha-1-Adrenergic receptor stimulation causes arachidonic acid release through pertussis toxin-sensitive GTP-binding protein and JNK activation in rabbit aortic smooth muscle cells

Biochemical and Biophysical Research Communications
E NishioY Watanabe

Abstract

In the present study, we investigated the mechanism of phenylephrine (alpha-1-adrenergic receptor agonist)-induced arachidonic acid release in Japanese white rabbit aortic smooth muscle cells (SMC). When introduced into permeabilized smooth muscle cells, guanosine S-[gamma-thio] triphosphate (GTPgamma S), which activates GTP-binding proteins (G proteins), stimulated arachidonic acid (AA) release. Neomycin, an inhibitor of phosphoinositide (PI) turnover, was almost without effect on GTP[gamma S] stimulated AA release. In addition, pertussis toxin (PT) partially inhibited phenylephrine-stimulated AA release, suggesting that IAP (Islet activating protein)-sensitive G proteins mediate this process. Phenylephrine-stimulated AA release was also inhibited by decreased extracellular calcium and aristolochic acid, suggesting a role for a phospholipase A2 (PLA2). Next PLA2 is reported to be a substrate for mitogen-activated protein (MAP) kinase. We examined the effect of phenylephrine on MAP kinase and c-jun N-terminal kinase (JNK) phosphorylation. Phenylephrine didn't induce phosphorylation of MAP kinase, but did induce phosphorylation of JNK. In addition, cells which were pretreated with PT inhibited the phosphorylation of JNK. These r...Continue Reading

Citations

May 9, 2002·Biological & Pharmaceutical Bulletin·Taka-aki KoshimizuGozoh Tsujimoto
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·X L Cui, J G Douglas
Jul 17, 1998·Circulation·C P TiefenbacherW M Chilian
Jan 6, 2006·The Journal of Pharmacology and Experimental Therapeutics·Rui ZhangKathleen M MacLeod
Feb 12, 1998·The American Journal of Physiology·E J FreemanR V Dorman
Sep 28, 2001·Biochemical and Biophysical Research Communications·R A Houliston, C P Wheeler-Jones
Jun 6, 2000·Trends in Neurosciences·M HernándezM Sánchez Crespo
Jul 28, 1999·European Journal of Pharmacology·E Nishio, Y Watanabe
Aug 12, 1999·European Journal of Pharmacology·H Zhong, K P Minneman
Feb 20, 2003·European Journal of Pharmacology·Andre S PupoKenneth P Minneman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.